InControl makes first atrial defibrillator implant:
This article was originally published in Clinica
Executive Summary
The first human implant of InControl's (US) Metrix atrial defibrillator was undertaken in London at the end of October. This is the first time an implantable defibrillator has been used for upper chamber therapy. InControl has tested the device in 17 humans, in four US electrophysiology laboratories since July, and plans to file an IDE for US implant trials in the next few months. Around four million people in the US and Europe suffer from atrial fibrillation and the American Heart Association estimates that more than 75,000 strokes a year in the US are associated with the rhythm disorder.